Remove study-cannabinoids-may-be-an-effective-adjunct-treatment-for-d
article thumbnail

Study: Cannabinoids May Be An Effective Adjunct Treatment for D

The Joint Blog

Cannabinoidsmay be an effective adjunct for the treatment of pancreatic cancer”, according to a new study. “Cannabinoid extracts may have anticancer properties, which can improve cancer treatment outcomes”, begins the study’s abstract.

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Marijuana & COVID-19: Top Studies [August 2020]

CannaMD

The COVID-19 abbreviation stands for “corona” (CO), “virus” (VI), “disease” (D), and “2019” (19). The CDC notes that individuals of all ages may contract COVID-19; however, the risk of death is significantly higher for older populations and those with underlying health conditions.

article thumbnail

Marijuana and Schizophrenia: Triggering or Treating?

Greencamp

An involvement of the endocannabinoid system with schizophrenia is supported both by the epidemiological observation that increased cannabis use is associated with a heightened risk for schizophrenia and that acute consumption of cannabis or synthetic cannabinoids can elicit psychotic symptoms in susceptible individuals.”. “An

article thumbnail

Can cannabis prevent or treat coronavirus?

Alchimia

These articles reported the findings of a study by Oregon State University into the effect that cannabis has on the cellular pathways that the COVID virus (an acronym for coronavirus disease) uses to invade the body. Let’s review the most notable scientific studies to date. No, cannabis is not a miracle cure for COVID-19.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

International Cannabinoid Cancer Research Institute (Draft 5). Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

They write… As the global COVID-19 pandemic drags on around the world, the damaging effects to mental health are becoming more and more apparent. there has never been a better time for new treatment options. This has spurred a variety of new scientific studies, new companies, and significant investor interest.